Disease-modifying and neuroprotective efficacy of exercise therapy early In the disease course of multiple sclerosis - The Early Multiple Sclerosis Exercise Study (EMSES)

M. Riemenschneider; L. G. Hvid; S. Ringgaard; M. K. E. Nygaard; S. F. Eskildsen; T. Gaemelke; M. Magyari; H. B. Jensen; H. H. Nielsen; M. Kant; M. Falah; T. Petersen; E. Stenager; U. Dalgas

Disease-modifying and neuroprotective efficacy of exercise therapy early In the disease course of multiple sclerosis - The Early Multiple Sclerosis Exercise Study (EMSES)

M. Riemenschneider, L. G. Hvid, S. Ringgaard, M. K. E. Nygaard, S. F. Eskildsen, T. Gaemelke, M. Magyari, H. B. Jensen, H. H. Nielsen, M. Kant, M. Falah, T. Petersen, E. Stenager, U. Dalgas

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	Multiple Sclerosis Journal
Volume	27
Issue number	Suppl. 2
Pages (from-to)	87
Number of pages	1
ISSN	1352-4585
Publication status	Published - 12. Oct 2021
Event	ECTRIMS 2021 - Amsterdam, Netherlands Duration: 13. Oct 2021 → 15. Oct 2021

Conference

Conference	ECTRIMS 2021
Country/Territory	Netherlands
City	Amsterdam
Period	13/10/2021 → 15/10/2021

Documents & Links

https://doi.org/10.1177/13524585211044647

SDU Link

Check access to the material in SDU Library's search engine

Cite this

Riemenschneider, M., Hvid, L. G., Ringgaard, S., Nygaard, M. K. E., Eskildsen, S. F., Gaemelke, T., Magyari, M., Jensen, H. B., Nielsen, H. H., Kant, M., Falah, M., Petersen, T., Stenager, E., & Dalgas, U. (2021). Disease-modifying and neuroprotective efficacy of exercise therapy early In the disease course of multiple sclerosis - The Early Multiple Sclerosis Exercise Study (EMSES). Multiple Sclerosis Journal, 27(Suppl. 2), 87. https://doi.org/10.1177/13524585211044647

@article{3d75ee956fae414388c2a4dc750a2c37,

title = "Disease-modifying and neuroprotective efficacy of exercise therapy early In the disease course of multiple sclerosis - The Early Multiple Sclerosis Exercise Study (EMSES)",

author = "M. Riemenschneider and Hvid, {L. G.} and S. Ringgaard and Nygaard, {M. K. E.} and Eskildsen, {S. F.} and T. Gaemelke and M. Magyari and Jensen, {H. B.} and Nielsen, {H. H.} and M. Kant and M. Falah and T. Petersen and E. Stenager and U. Dalgas",

year = "2021",

month = oct,

day = "12",

language = "English",

volume = "27",

pages = "87",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications",

number = "Suppl. 2",

note = "ECTRIMS 2021 ; Conference date: 13-10-2021 Through 15-10-2021",

}

Riemenschneider, M, Hvid, LG, Ringgaard, S, Nygaard, MKE, Eskildsen, SF, Gaemelke, T, Magyari, M, Jensen, HB , Nielsen, HH, Kant, M, Falah, M, Petersen, T, Stenager, E & Dalgas, U 2021, 'Disease-modifying and neuroprotective efficacy of exercise therapy early In the disease course of multiple sclerosis - The Early Multiple Sclerosis Exercise Study (EMSES)', Multiple Sclerosis Journal, vol. 27, no. Suppl. 2, pp. 87. <https://doi.org/10.1177/13524585211044647>

Disease-modifying and neuroprotective efficacy of exercise therapy early In the disease course of multiple sclerosis - The Early Multiple Sclerosis Exercise Study (EMSES). / Riemenschneider, M.; Hvid, L. G.; Ringgaard, S. et al.
In: Multiple Sclerosis Journal, Vol. 27, No. Suppl. 2, 12.10.2021, p. 87.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Disease-modifying and neuroprotective efficacy of exercise therapy early In the disease course of multiple sclerosis - The Early Multiple Sclerosis Exercise Study (EMSES)

AU - Riemenschneider, M.

AU - Hvid, L. G.

AU - Ringgaard, S.

AU - Nygaard, M. K. E.

AU - Eskildsen, S. F.

AU - Gaemelke, T.

AU - Magyari, M.

AU - Jensen, H. B.

AU - Nielsen, H. H.

AU - Kant, M.

AU - Falah, M.

AU - Petersen, T.

AU - Stenager, E.

AU - Dalgas, U.

PY - 2021/10/12

Y1 - 2021/10/12

M3 - Conference abstract in journal

SN - 1352-4585

VL - 27

SP - 87

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

IS - Suppl. 2

T2 - ECTRIMS 2021

Y2 - 13 October 2021 through 15 October 2021

ER -